UNSPSC 51113201: Azatepa

This classification denotes an ethylenimine compound with the molecular formula C8H14N5OPS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D57I4Z650L, chemically known as p,p-bis(1-aziridinyl)-n-ethyl-n-1,3,4-thiadiazol-2-ylphosphinic amide but more generally known as azatepa, which bears US NIH Compound Identifier 31321. European Medicines Agency schedules Azatepa in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05646MIG.

UNSPSC 51113201 Azatepa, a Commodity code, covers pharmaceutical products and related services that state and local governments procure, including specialty medications and direct-to-manufacturer prescription fulfillment programs. State health and human services agencies are the primary buyers under this code, sourcing both medications themselves and vendor services to establish alternative distribution channels that bypass traditional pharmacy benefit managers and group purchasing organizations. The code spans pharmaceutical procurement at the state agency level, where the focus includes negotiating direct manufacturer relationships, implementing value-based pricing models, and managing prescription fulfillment efficiency for employee health plans and state beneficiary populations.

Texas Health and Human Services Commission posted Request for Information HHS0017013 on April 3, 2026, seeking vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program. The RFI solicits information from vendors with experience in direct contracting for self-insured employers and government health plans, the ability to negotiate net pricing models without rebates, and capacity to implement outcomes-based agreements. The RFI represents an exploratory procurement phase designed to inform the state's future formal solicitation strategy before issuing a formal RFP with established financial and temporal parameters. No award value, budget range, or set-aside designations are specified at this stage, reflecting the state's foundational research into available solutions and vendor capabilities.